This interpretation would fit well with the hypothesis of an amyloid-independent phase of AD [100], a phase in which dysregulation of GluA2 Q/R site editing may play a major role in driving the development of some AD-phenotypes. The gene discussed is GRIA2; the disease is Alzheimer disease.